Pravastatin Reduces Mortality 10 Years After Use – Study
This article was originally published in The Tan Sheet
Executive Summary
Results of a follow-up primary prevention trial finding treatment with pravastatin provided ongoing cardiac event risk reduction 10 years later could strengthen the case for OTC statins